av/zealand-pharma-a-s--big.svg

COM:ZEALANDPHARMA

Zealand Pharma A/S

  • Stock

Last Close

697.00

22/11 15:59

Market Cap

65.70B

Beta: -

Volume Today

138.73K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-183.68M
-
-64.99M
64.62%
-113.96M
75.35%
-153.91M
35.06%
-272.27M
76.90%
581.28M
313.49%
-571.54M
198.32%
-846.73M
48.15%
-1.02B
20.24%
-1.20B
18.07%
-703.74M
41.46%
depreciation and amortization
5.91M
-
5.93M
0.36%
6.21M
4.77%
5.41M
12.95%
4.76M
12.07%
4.51M
5.23%
13.68M
203.50%
42.69M
212.03%
40.25M
5.72%
117.96M
193.08%
28.30M
76.01%
deferred income tax
4.79M
-
-523K
110.92%
-34.25M
6,449.14%
-5.50M
83.94%
-5.50M
0%
43.77M
895.89%
-5.38M
112.30%
9.87M
283.19%
-1.19M
112.06%
-94.47M
-
stock based compensation
8.80M
-
1.67M
80.98%
16.95M
912.37%
22.73M
34.11%
20.16M
11.31%
17.47M
13.34%
14.76M
15.49%
30.48M
106.50%
53.50M
75.51%
52.58M
1.73%
61.43M
16.83%
change in working capital
-3.64M
-
16.77M
560.36%
-138.87M
928.04%
153.45M
210.50%
-14.29M
109.31%
12.79M
189.46%
10.87M
14.96%
97.82M
799.64%
-166.32M
270.04%
10.26M
106.17%
52.10M
407.68%
accounts receivables
-4.45M
-
-21.06M
-
-7.72M
63.36%
-64.49M
735.85%
18.22M
128.25%
-18.61M
202.11%
inventory
4.00M
-
-14.40M
460.28%
-52.77M
266.37%
50.69M
196.06%
9.34M
81.58%
accounts payables
805K
-
17.06M
-
119.94M
603.00%
-49.06M
140.90%
-58.65M
19.55%
32.84M
155.99%
other working capital
10.87M
-
28.53M
-
other non cash items
-1.80M
-
-1.05M
41.87%
38.51M
3,777.65%
18.73M
51.37%
-11.60M
161.93%
-1.12B
9,559.54%
128.15M
111.44%
-22.85M
117.83%
-120.06M
425.50%
79.13M
165.91%
230.70M
191.56%
net cash provided by operating activities
-169.62M
-
-42.18M
75.13%
-225.41M
434.37%
40.90M
118.15%
-278.75M
781.46%
-460.40M
65.17%
-409.45M
11.07%
-688.72M
68.20%
-1.21B
75.98%
-942.21M
22.26%
-425.67M
54.82%
investments in property plant and equipment
-4.57M
-
-4.50M
1.58%
-4.04M
10.16%
-2.60M
35.64%
-7.23M
177.92%
-4.04M
44.12%
-23.52M
482.37%
-25.04M
6.50%
-22.13M
11.62%
-11.71M
47.09%
-23.75M
102.81%
acquisitions net
25K
-
-167.79M
671,264%
106.39M
-
purchases of investments
-47.36M
-
-84.35M
-
-299.85M
255.49%
-22.80M
92.40%
-700.48M
-
-2.16B
208.34%
sales maturities of investments
148.75M
-
24.38M
83.61%
74.23M
-
-25K
100.03%
887.06M
-
1.09B
22.83%
other investing activites
-17K
-
-123K
623.53%
27K
121.95%
-297.36M
1,101,425.93%
312.93M
205.24%
1.11B
255.22%
-5.35M
100.48%
-3.97M
25.72%
4.01M
201.01%
net cash used for investing activites
96.81M
-
19.76M
79.59%
-4.01M
120.31%
-299.96M
7,374.66%
221.35M
173.79%
881.90M
298.42%
-51.67M
105.86%
-196.81M
280.92%
-18.12M
90.79%
281.26M
1,652.12%
-1.09B
488.98%
debt repayment
-176.36M
-
-158.31M
10.23%
-8.69M
94.51%
-29.22M
236.28%
-14.71M
49.64%
-436.09M
2,863.56%
-525.76M
20.56%
common stock issued
96.41M
-
135.21M
40.24%
567.08M
319.40%
697.61M
-
832.87M
19.39%
775.04M
6.94%
1.08B
39.95%
1.49B
37.56%
common stock repurchased
-28.59M
-
-41.60M
-
dividends paid
-647.91M
-
other financing activites
272.17M
-
21.93M
-
-52.79M
340.65%
2.86M
105.42%
-14.44M
604.68%
-42.71M
195.67%
1.25B
3,024.45%
-61.17M
104.90%
-17.66M
71.13%
net cash used provided by financing activities
272.17M
-
96.41M
64.58%
157.15M
62.99%
337.93M
115.04%
-155.45M
146.00%
674.48M
533.89%
760.94M
12.82%
1.33B
75.15%
587.40M
55.93%
907.01M
54.41%
effect of forex changes on cash
141K
-
2.35M
1,563.12%
34.94M
1,389.94%
6.44M
81.56%
-15.15M
335.13%
5.86M
138.69%
7.07M
20.56%
3.74M
47.03%
66.22M
1,669.25%
13.68M
79.34%
-7.24M
152.89%
net change in cash
-72.67M
-
252.09M
446.91%
-98.07M
138.90%
-95.47M
2.66%
265.39M
377.99%
271.92M
2.46%
220.43M
18.94%
-120.84M
154.82%
168.88M
239.76%
-59.87M
135.45%
-619.92M
935.47%
cash at beginning of period
358.85M
-
286.18M
20.25%
538.27M
88.09%
418.80M
22.20%
323.33M
22.80%
588.72M
82.08%
860.63M
46.19%
1.08B
25.61%
960.22M
11.18%
1.13B
17.59%
1.07B
5.30%
cash at end of period
286.18M
-
538.27M
88.09%
440.20M
18.22%
323.33M
26.55%
588.72M
82.08%
860.63M
46.19%
1.08B
25.61%
960.22M
11.18%
1.13B
17.59%
1.07B
5.30%
449.31M
57.98%
operating cash flow
-169.62M
-
-42.18M
75.13%
-225.41M
434.37%
40.90M
118.15%
-278.75M
781.46%
-460.40M
65.17%
-409.45M
11.07%
-688.72M
68.20%
-1.21B
75.98%
-942.21M
22.26%
-425.67M
54.82%
capital expenditure
-4.57M
-
-4.50M
1.58%
-4.04M
10.16%
-2.60M
35.64%
-7.23M
177.92%
-4.04M
44.12%
-23.52M
482.37%
-25.04M
6.50%
-22.13M
11.62%
-11.71M
47.09%
-23.75M
102.81%
free cash flow
-174.19M
-
-46.68M
73.20%
-229.45M
391.54%
38.30M
116.69%
-285.97M
846.59%
-464.44M
62.41%
-432.97M
6.78%
-713.76M
64.85%
-1.23B
72.90%
-953.92M
22.70%
-449.42M
52.89%

All numbers in (except ratios and percentages)